Inclusion | Exclusion |
---|---|
• Male and female subjects • Age 18-30 years • Good general health: free of systemic diseases such as diabetes, HIV infection or genetic disorder, ongoing malignant disease of any type that could interfere with the evaluation of the study objectives • Good oral health: free of oral pathologies such as leukoplakia, erythroplakia, oral lichen planus (OLP) • Availability for the 6-month duration of the study for an assigned subject • Signed Informed Consent Form | • Pregnant or lactating women • More than 8 missing teeth (with missing teeth, accounted for by third molar extractions, teeth extracted for orthodontic purposes, teeth extracted because of trauma, or congenitally missing teeth) • Presence of orthodontic appliances • Chronic dry mouth (clinically assessed) • Significant halitosis (clinically assessed) • Periodontitis • Untreated carious lesions or oral abscesses • Current or past (within 3 months before enrolment) assumption of medications that may influence oral microbiome (corticosteroids, calcium channel blockers, systemic antibiotics). • Non-surgical and/or surgical mechanical/manual periodontal debridement within 3 months before enrolment. • Heart diseases or blood pressure alteration that requires a medication • Renal, hepatic, gastrointestinal disease that requires a medication • Diabetes • Presence of any sexually transmitted disease (STD), HIV, HCV infection • Genetic disorders potentially interfering with the evaluation of the study objectives • Chronic obstructive pulmonary disease and asthma • Neoplastic lesions or paraneoplastic syndrome; tumors or significant pathology of the soft or hard tissues of the oral cavity (such as LPO, erythroplakia, leukoplakia, candidiasis) • Current radiotherapy or chemotherapy |